
SPRAVATO, First New Depression Medication In 30 Years, Approved by FDA
In a historic 14-to-2 vote the FDA has approved Janssen Pharmaceuticals new medication, Spravato, for clinical depression.
In a historic 14-to-2 vote the FDA has approved Janssen Pharmaceuticals new medication, Spravato, for clinical depression.
In the final month of 2018, the CDC has released a report of the drugs that have been involved in the most deaths from 2011 to 2016.
In May of 2018, the FDA approved Lucemyra, a new medication to treat the symptoms of opioid withdrawal. It is available as of August of 2018.
In June, the FDA approved Epidiolex as the medication available in the United States which is made from cannabis. Learn why that's important.
Despite the ongoing opioid epidemic, the FDA has approved Dsuvia, a synthetic opioid that is 10 times more potent than fentanyl.
While the potential downfall new technologies are often debated, video game addiction has been hooking children and adults for the past 20 years.
If you are worried that you or a loved one is addicted to pornography, it is important to know the top 10 signs of porn addiction.
Behavioral addictions or non-substance addictions, like gambling addiction, are a set of behaviors that a person becomes dependent on and craves.
On October 3rd, 2018, the Senate passed an opioid package that contained several bills that have all faced contention in the past.